13F Filings History of COWEN AND COMPANY, LLC

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • COWEN AND COMPANY, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • COWEN AND COMPANY, LLC reported 542 equity holdings with a total reported market value of $2,899,009,920 for Q3 2024. Top reported holdings included NVDA, COIN, META, AMZN, and MSFT.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Jeffrey Sundram - Chief Compliance Officer
Manager location
New York, NY

Follow Filing Activity

Follow COWEN AND COMPANY, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q3 2024
Latest value
$2,899,009,920
Quarter delta
$0
Accepted
12 Nov 2024, 09:15
Rows shown
1-22 of 22
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q4 2024 0 $0 $0 -$2,899,009,920 -$2,899,009,920 13F-HR 14 Feb 2025, 16:00
Q3 2024 542 $2,899,009,920 +$685,596,308 -$1,482,559,237 -$796,962,929 NVDA, COIN, META, AMZN, MSFT 13F-HR 12 Nov 2024, 09:15
Q2 2024 545 $3,611,138,050 +$1,971,823,866 -$330,116,670 +$1,641,707,196 NVDA, META, COIN, AAPL, RNA 13F-HR 07 Aug 2024, 10:09
Q1 2024 601 $2,559,186,373 +$1,084,405,204 -$489,816,381 +$594,588,823 NVDA, COIN, RNA, META, PTCT 13F-HR 03 May 2024, 07:57
Q4 2023 588 $1,524,575,267 +$540,842,917 -$548,209,814 -$7,366,897 NVDA, PTCT, COIN, RNA, SIRI Restatement 12 Feb 2024, 10:15
Q3 2023 590 $1,424,076,722 +$677,693,091 -$332,839,667 +$344,853,424 NVDA, ESTA, XLE, MSOS, AAC 13F-HR 09 Nov 2023, 16:59
Q2 2023 582 $1,205,464,702 +$666,859,569 -$326,079,832 +$340,779,737 NVDA, ESTA, RNA, PTGX, MMP 13F-HR 07 Aug 2023, 14:37
Q1 2023 547 $849,818,210 +$291,382,294 -$324,214,176 -$32,831,882 SLVM, RNA, ESTA, AVDL, STOK 13F-HR 09 May 2023, 14:49
Q4 2022 595 $943,538,550 +$282,891,297 -$389,777,411 -$106,886,114 SLVM, RNA, DCP, ESTA, REVANCE THERAPEUTICS INC 13F-HR 09 Feb 2023, 12:14
Q3 2022 661 $981,920,000 +$204,214,588 -$242,625,681 -$38,411,093 ARKK, SLVM, RNA, IMCR, ESTA 13F-HR 14 Nov 2022, 16:01
Q2 2022 552 $1,013,616,000 +$447,809,902 -$191,383,282 +$256,426,620 ARKK, SLVM, ESTA, DISH NETWORK CORPORATION, ACET 13F-HR 05 Aug 2022, 14:59
Q1 2022 487 $985,387,000 +$497,853,019 -$461,501,579 +$36,351,440 FULC, ARKK, SLVM, ESTA, FTAI 13F-HR 16 May 2022, 08:15
Q4 2021 485 $1,045,694,000 +$565,128,340 -$1,420,944,243 -$855,815,903 IPOF, ESTA, FTAI, SMFG, CTLP 13F-HR 14 Feb 2022, 17:01
Q3 2021 390 $2,050,366,000 +$442,692,585 -$264,870,838 +$177,821,747 QQQ, HYG, SPY, LOW, HD 13F-HR 12 Nov 2021, 12:48
Q2 2021 396 $1,882,846,000 +$804,943,545 -$393,605,402 +$411,338,143 QQQ, HYG, SPY, LOW, HD 13F-HR 13 Aug 2021, 09:44
Q1 2021 347 $1,415,983,000 $0 $0 $0 HYG, QQQ, LQD, IWM, SPY 13F-HR 04 May 2021, 14:17
Q4 2020 228 $1,076,605,000 $0 $0 $0 QQQ, LQD, HYG, IWM, SPY 13F-HR 08 Feb 2021, 08:20
Q3 2020 266 $563,642,000 $0 $0 $0 QQQ, NKLA, SMFG, ALBO, IWM 13F-HR 03 Nov 2020, 08:59
Q2 2020 245 $542,888,000 $0 $0 $0 NKLA, QQQ, SMFG, CCL, BLU 13F-HR 13 Aug 2020, 12:49
Q1 2020 256 $380,208,000 $0 $0 $0 QQQ, SMFG, MTCH, XOM, SPY 13F-HR 11 May 2020, 16:52
Q4 2019 277 $1,102,601,000 $0 $0 $0 QQQ, AAPL, SPY, SMFG, FRCB 13F-HR 11 Feb 2020, 17:14
Q3 2019 294 $368,016,000 $0 $0 $0 SMFG, ZM, CRWD, BYND, TDAC 13F-HR 12 Nov 2019, 10:43
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .